BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1338 related articles for article (PubMed ID: 15236877)

  • 1. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
    Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
    Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment results of 59 young patients with nasopharyngeal carcinoma.
    Selek U; Ozyar E; Ozyigit G; Varan A; Buyukpamukcu M; Atahan IL
    Int J Pediatr Otorhinolaryngol; 2005 Feb; 69(2):201-7. PubMed ID: 15656953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
    Song CH; Wu HG; Heo DS; Kim KH; Sung MW; Park CI
    Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
    Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
    Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy.
    Chua DT; Nicholls JM; Sham JS; Au GK
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):11-20. PubMed ID: 15093894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy followed by concurrent chemo-radiation therapy in locally advanced nasopharyngeal carcinoma.
    Al-Amro A; Al-Rajhi N; Khafaga Y; Memon M; Al-Hebshi A; El-Enbabi A; El-Husseiny G; Radawi A; Belal A; Allam A; El-Sebaie M
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):508-13. PubMed ID: 15890594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.
    Turen S; Ozyar E; Altundag K; Gullu I; Atahan IL
    Cancer Invest; 2007 Aug; 25(5):315-21. PubMed ID: 17661206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: a Rare Cancer Network study.
    Ozyar E; Selek U; Laskar S; Uzel O; Anacak Y; Ben-Arush M; Polychronopoulou S; Akman F; Wolden SL; Sarihan S; Miller RC; Ozsahin M; Abacioğlu U; Martin M; Caloglu M; Scandolaro L; Szutowicz E; Atahan IL
    Radiother Oncol; 2006 Oct; 81(1):39-46. PubMed ID: 16965827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma.
    Chua DT; Wei WI; Sham JS; Cheng AC; Au G
    Head Neck; 2003 Jul; 25(7):585-94. PubMed ID: 12808662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
    Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation of pretreatment serum level of endostatin to posttreatment distant metastasis in patients with advanced nasopharyngeal carcinoma].
    Zhao ZJ; Mo HY; Zhang CQ; Qi B; Li J; Hong MH; Mai HQ
    Ai Zheng; 2007 Nov; 26(11):1243-7. PubMed ID: 17991326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasopharyngeal cancer in the Middle East: experience of the American University of Beirut Medical Center.
    Geara FB; Nasr E; Tucker SL; Brihi E; Zaytoun G; Hadi U; Salem Z; El Saghir N; Issa P; Shamseddine A
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1408-15. PubMed ID: 15817344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment results of 1070 patients with nasopharyngeal carcinoma: an analysis of survival and failure patterns.
    Leung TW; Tung SY; Sze WK; Wong FC; Yuen KK; Lui CM; Lo SH; Ng TY; O SK
    Head Neck; 2005 Jul; 27(7):555-65. PubMed ID: 15880410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma. A significant factor in local control and distant metastasis.
    Chua DT; Sham JS; Kwong DL; Choy DT; Au GK; Wu PM
    Cancer; 1996 Jul; 78(2):202-10. PubMed ID: 8673993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
    Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
    Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
    Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
    Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
    Chua DT; Sham JS; Choy D; Lorvidhaya V; Sumitsawan Y; Thongprasert S; Vootiprux V; Cheirsilpa A; Azhar T; Reksodiputro AH
    Cancer; 1998 Dec; 83(11):2270-83. PubMed ID: 9840526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.